🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study on Basal Joint Arthritis Prospective

Recruitingn/aAges 18 Years - anyAllColumbia University
NCT01376024 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The data in this prospective registry will be used 1) to define which surgical and nonoperative techniques are most effective at providing pain relief, restoring function, are cost effective, and patients are satisfied with their outcomes; and 2) to design focused clinical questions regarding the optimal treatment of basal joint arthritis of the thumb in future randomized controlled trials. There are no interventions or changes in patient care associated with this study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients who have symptomatic basal joint arthritis. * Patients who are capable of providing informed consent. Exclusion Criteria: * Patients younger than 18 years old at the time of enrollment. * Patients with neuromuscular disease affecting the operated hand, not caused by the CMC operation. * Patients with known inflammatory arthritic conditions, such as rheumatoid or psoriatic arthritis. * Patients with a history of or current infection of the basal joint of the affected hand. * Patients who are demented or are unable to provide informed consent. * Patients unable to comply with study guidelines. * Patients who have metacarpophalangeal joint hyperextension are NOT excluded. These patients will be followed and if they receive a capsulodesis or other procedure at the MCPJ at the same time as their basal joint arthroplasty this will be noted in their data records.
💊

What it tests

  • Not listed
📍

Where

3 sites
Mayo Clinic
Rochester, United States
Columbia University/NY Presbyterian Hospital
New York, United States
Vanderbilt University Hospital
Nashville, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy